A Randomized, Evaluator‐Blinded, Controlled Study of the Effectiveness and Safety of Small Gel Particle Hyaluronic Acid for Lip Augmentation

Objectives To assess the effectiveness and safety of small gel particle hyaluronic acid (SGP‐HA) for lip augmentation. Methods Adults (n = 180; aged 18–65) scoring 1 (very thin) to 2 (thin) on the 5‐point validated Medicis Lip Fullness Scale (MLFS) for the upper or lower lip were randomized (3:1) to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatologic surgery 2012-07, Vol.38 (7pt2), p.1180-1192
Hauptverfasser: Glogau, Richard G., Bank, David, Brandt, Fredric, Cox, Sue Ellen, Donofrio, Lisa, Dover, Jeffrey, Grekin, Steven, Lawrence, Ira, Lin, Xiaoming, Nestor, Mark, Shamban, Ava, Stewart, Daniel, Weiss, Robert, Axford‐Gatley, Robert A., Theisen, Michael J., Smith, Stacy
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To assess the effectiveness and safety of small gel particle hyaluronic acid (SGP‐HA) for lip augmentation. Methods Adults (n = 180; aged 18–65) scoring 1 (very thin) to 2 (thin) on the 5‐point validated Medicis Lip Fullness Scale (MLFS) for the upper or lower lip were randomized (3:1) to SGP‐HA (≤1.5 mL/lip) or no treatment. Co‐primary effectiveness end points were blinded‐evaluator MLFS score for upper or lower lip at week 8. Secondary end points (MLFS score, independent photographic review, Global Aesthetic Improvement Scale [GAIS], safety assessments) were measured throughout the study. Results Statistically significantly more MLFS responders (≥1 grades of MLFS improvement at week 8) received SGP‐HA (93% combined upper and lower lip responders [95% upper lip; 94% lower lip]) than no treatment (29% combined; p 
ISSN:1076-0512
1524-4725
DOI:10.1111/j.1524-4725.2012.02473.x